Guidance A-Z — N
81 guidance documents beginning with N.
Naldemedine for treating opioid-induced constipation
Nalmefene for reducing alcohol consumption in people with alcohol dependence
Naloxegol for treating opioid‑induced constipation
Naltrexone for the management of opioid dependence
Naltrexone–bupropion for managing overweight and obesity
Narcolepsy with or without cataplexy in adults: pitolisant
Narrow band imaging for Barrett's oesophagus
Nasal Alar SpO2 sensor for monitoring oxygen saturation by pulse oximetry
Natalizumab (originator and biosimilar) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy
Natalizumab for treating rapidly evolving severe relapsing–remitting multiple sclerosis
National Early Warning Score systems that alert to deteriorating adult patients in hospital
NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wounds
Natural Cycles for monitoring fertility
NaviCam for diagnosing gastrointestinal tract conditions
NBTXR-3 for treating advanced soft tissue sarcoma (terminated appraisal)
Necitumumab for untreated advanced or metastatic squamous non-small-cell lung cancer
Needle and syringe programmes
Needle-free arterial non-injectable connector
Negative pressure wound therapy for the open abdomen
Nemolizumab for treating moderate to severe atopic dermatitis in people 12 years and over
Neo Pedicle Screw System for spinal fusion surgery
Neon EEG electrode for EEG monitoring in newborns
Neonatal infection
Neonatal infection: antibiotics for prevention and treatment
Neonatal parenteral nutrition
Neonatal parenteral nutrition
Neratinib for extended adjuvant treatment of hormone receptor-positive, HER2-positive early stage breast cancer after adjuvant trastuzumab
Nerve graft for corneal denervation
Nerve transfer to partially restore upper limb function in tetraplegia
Neuropad for detecting preclinical diabetic peripheral neuropathy
Neuropathic pain in adults: pharmacological management in non-specialist settings
Neurostimulation of lumbar muscles for refractory non-specific chronic low back pain
Neutropenic sepsis: prevention and management in people with cancer
New generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scanners
Next-generation sequencing panel for solid tumour cancers in children
Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non‑small‑cell lung cancer
Nintedanib for treating fibrosing interstitial lung disease in people 6 to 17 years (terminated appraisal)
Nintedanib for treating idiopathic pulmonary fibrosis
Nintedanib for treating idiopathic pulmonary fibrosis when forced vital capacity is above 80% predicted
Nintedanib for treating progressive fibrosing interstitial lung diseases
Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy
Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer
Niraparib with abiraterone acetate and prednisone for untreated hormone-relapsed metastatic prostate cancer (terminated appraisal)
Nirmatrelvir plus ritonavir and tocilizumab for treating COVID-19
Nivolumab for adjuvant treatment of completely resected melanoma at high risk of recurrence in people 12 years and over (terminated appraisal)
Nivolumab for adjuvant treatment of completely resected melanoma with lymph node involvement or metastatic disease
Nivolumab for adjuvant treatment of invasive urothelial cancer at high risk of recurrence
Nivolumab for adjuvant treatment of resected oesophageal or gastro-oesophageal junction cancer
Nivolumab for advanced non-squamous non-small-cell lung cancer after chemotherapy
Nivolumab for advanced squamous non-small-cell lung cancer after chemotherapy
Nivolumab for previously treated advanced renal cell carcinoma
Nivolumab for previously treated unresectable advanced or recurrent oesophageal cancer
Nivolumab for treating advanced (unresectable or metastatic) melanoma
Nivolumab for treating locally advanced unresectable or metastatic urothelial cancer after platinum-containing chemotherapy
Nivolumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy
Nivolumab for treating relapsed or refractory classical Hodgkin lymphoma
Nivolumab in combination with ipilimumab for treating advanced melanoma
Nivolumab plus ipilimumab for untreated unresectable or metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency
Nivolumab with cabozantinib for untreated advanced renal cell carcinoma (terminated appraisal)
Nivolumab with chemotherapy for neoadjuvant treatment of resectable non-small-cell lung cancer
Nivolumab with chemotherapy for neoadjuvant treatment then alone for adjuvant treatment of resectable non-small-cell lung cancer
Nivolumab with chemotherapy for untreated unresectable or metastatic urothelial cancer (terminated appraisal)
Nivolumab with fluoropyrimidine- and platinum-based chemotherapy for untreated unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinoma
Nivolumab with ipilimumab and chemotherapy for untreated metastatic non-small-cell lung cancer
Nivolumab with ipilimumab for previously treated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency
Nivolumab with ipilimumab for untreated advanced renal cell carcinoma
Nivolumab with ipilimumab for untreated unresectable malignant pleural mesothelioma
Nivolumab with platinum- and fluoropyrimidine-based chemotherapy for untreated HER2-negative advanced gastric, gastro-oesophageal junction or oesophageal adenocarcinoma
Nivolumab–relatlimab for untreated unresectable or metastatic melanoma in people 12 years and over
Noctura 400 Sleep Mask for diabetic retinopathy and diabetic macular oedema
Nogapendekin alfa inbakicept with BCG for non-muscle-invasive bladder cancer with carcinoma in situ that is unresponsive to BCG (terminated evaluation)
Non-alcoholic fatty liver disease (NAFLD): assessment and management
Non-Hodgkin lymphoma: diagnosis and management
Non-Hodgkin's lymphoma: rituximab subcutaneous injection
Non-rigid stabilisation techniques for the treatment of low back pain
Normothermic extracorporeal preservation of hearts for transplantation following donation after brainstem death
Novii Wireless Patch System for maternal and fetal monitoring
NPi-200 for pupillary light reflex in critical care patients
Nusinersen and risdiplam for treating spinal muscular atrophy
Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition
Nutrition support in adults
Nalmefene for reducing alcohol consumption in people with alcohol dependence
Naloxegol for treating opioid‑induced constipation
Naltrexone for the management of opioid dependence
Naltrexone–bupropion for managing overweight and obesity
Narcolepsy with or without cataplexy in adults: pitolisant
Narrow band imaging for Barrett's oesophagus
Nasal Alar SpO2 sensor for monitoring oxygen saturation by pulse oximetry
Natalizumab (originator and biosimilar) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy
Natalizumab for treating rapidly evolving severe relapsing–remitting multiple sclerosis
National Early Warning Score systems that alert to deteriorating adult patients in hospital
NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wounds
Natural Cycles for monitoring fertility
NaviCam for diagnosing gastrointestinal tract conditions
NBTXR-3 for treating advanced soft tissue sarcoma (terminated appraisal)
Necitumumab for untreated advanced or metastatic squamous non-small-cell lung cancer
Needle and syringe programmes
Needle-free arterial non-injectable connector
Negative pressure wound therapy for the open abdomen
Nemolizumab for treating moderate to severe atopic dermatitis in people 12 years and over
Neo Pedicle Screw System for spinal fusion surgery
Neon EEG electrode for EEG monitoring in newborns
Neonatal infection
Neonatal infection: antibiotics for prevention and treatment
Neonatal parenteral nutrition
Neonatal parenteral nutrition
Neratinib for extended adjuvant treatment of hormone receptor-positive, HER2-positive early stage breast cancer after adjuvant trastuzumab
Nerve graft for corneal denervation
Nerve transfer to partially restore upper limb function in tetraplegia
Neuropad for detecting preclinical diabetic peripheral neuropathy
Neuropathic pain in adults: pharmacological management in non-specialist settings
Neurostimulation of lumbar muscles for refractory non-specific chronic low back pain
Neutropenic sepsis: prevention and management in people with cancer
New generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scanners
Next-generation sequencing panel for solid tumour cancers in children
Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non‑small‑cell lung cancer
Nintedanib for treating fibrosing interstitial lung disease in people 6 to 17 years (terminated appraisal)
Nintedanib for treating idiopathic pulmonary fibrosis
Nintedanib for treating idiopathic pulmonary fibrosis when forced vital capacity is above 80% predicted
Nintedanib for treating progressive fibrosing interstitial lung diseases
Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy
Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer
Niraparib with abiraterone acetate and prednisone for untreated hormone-relapsed metastatic prostate cancer (terminated appraisal)
Nirmatrelvir plus ritonavir and tocilizumab for treating COVID-19
Nivolumab for adjuvant treatment of completely resected melanoma at high risk of recurrence in people 12 years and over (terminated appraisal)
Nivolumab for adjuvant treatment of completely resected melanoma with lymph node involvement or metastatic disease
Nivolumab for adjuvant treatment of invasive urothelial cancer at high risk of recurrence
Nivolumab for adjuvant treatment of resected oesophageal or gastro-oesophageal junction cancer
Nivolumab for advanced non-squamous non-small-cell lung cancer after chemotherapy
Nivolumab for advanced squamous non-small-cell lung cancer after chemotherapy
Nivolumab for previously treated advanced renal cell carcinoma
Nivolumab for previously treated unresectable advanced or recurrent oesophageal cancer
Nivolumab for treating advanced (unresectable or metastatic) melanoma
Nivolumab for treating locally advanced unresectable or metastatic urothelial cancer after platinum-containing chemotherapy
Nivolumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy
Nivolumab for treating relapsed or refractory classical Hodgkin lymphoma
Nivolumab in combination with ipilimumab for treating advanced melanoma
Nivolumab plus ipilimumab for untreated unresectable or metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency
Nivolumab with cabozantinib for untreated advanced renal cell carcinoma (terminated appraisal)
Nivolumab with chemotherapy for neoadjuvant treatment of resectable non-small-cell lung cancer
Nivolumab with chemotherapy for neoadjuvant treatment then alone for adjuvant treatment of resectable non-small-cell lung cancer
Nivolumab with chemotherapy for untreated unresectable or metastatic urothelial cancer (terminated appraisal)
Nivolumab with fluoropyrimidine- and platinum-based chemotherapy for untreated unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinoma
Nivolumab with ipilimumab and chemotherapy for untreated metastatic non-small-cell lung cancer
Nivolumab with ipilimumab for previously treated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency
Nivolumab with ipilimumab for untreated advanced renal cell carcinoma
Nivolumab with ipilimumab for untreated unresectable malignant pleural mesothelioma
Nivolumab with platinum- and fluoropyrimidine-based chemotherapy for untreated HER2-negative advanced gastric, gastro-oesophageal junction or oesophageal adenocarcinoma
Nivolumab–relatlimab for untreated unresectable or metastatic melanoma in people 12 years and over
Noctura 400 Sleep Mask for diabetic retinopathy and diabetic macular oedema
Nogapendekin alfa inbakicept with BCG for non-muscle-invasive bladder cancer with carcinoma in situ that is unresponsive to BCG (terminated evaluation)
Non-alcoholic fatty liver disease (NAFLD): assessment and management
Non-Hodgkin lymphoma: diagnosis and management
Non-Hodgkin's lymphoma: rituximab subcutaneous injection
Non-rigid stabilisation techniques for the treatment of low back pain
Normothermic extracorporeal preservation of hearts for transplantation following donation after brainstem death
Novii Wireless Patch System for maternal and fetal monitoring
NPi-200 for pupillary light reflex in critical care patients
Nusinersen and risdiplam for treating spinal muscular atrophy
Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition
Nutrition support in adults